MANILA, Philippines, Oct. 19, 2026 /PRNewswire/ -- Salmon Group, a technology-driven banking and lending platform in the ...

Alexandre Bompard, CEO of Carrefour, said in a post on X that 50 of the chain's stores had been looted during mass protests this weekend. Repair work will cost more than 10 million euros ($11.2 ...

Rheinmetall said it and Swiss shipping company Mediterranean Shipping Co. agreed to buy the Romanian Mangalia shipyard for 138 million euros ($155.1 million). The German defense group said Monday that ...

Sentiment across the region was weighed down by Wall Street's losses on Friday, which were hammered by AI infrastructure stocks. The Philadelphia Semiconductor Index tumbled 3.8% on Friday while the ...

Recent attacks by Houthi rebels are making U.S. executives nervous to travel to the Future Investment Initiative conference in Saudi Arabia next week. The artificial intelligence build-out hasn't ...

Marketing chief Julia Goldin says Lego is creating buildings sets around passions that cross demographic boundaries, such as gaming and Formula One. AI Agents Trading Stocks While You Sleep? Charles ...

U.S. Treasury yields fell in Asian trade on Monday as oil prices declined, allowing yields to remain comfortably below recent multidecade highs at the long end of the curve.

In December 2025, during the 6th China‑Russia Media Forum in Beijing, the two sides signed a media cooperation agreement for ...

Poxel reported revenue of €1,951k in the third quarter of 2026, including a €322k retroactive adjustment to royalties from the second quarter of 2026. Sumitomo Pharma expects net sales of TWYMEEG® to ...

Trend Micro Incorporated (TSE: 4704) today announced plans for the Japan Cyber Resilience Initiative, a major national effort ...

UBS Group AG reported in its first notification dated 13 October 2026, that on 8 October 2026, following an acquisition of shares with voting rights and equivalent financial instruments, UBS Group AG ...

Zealand Pharma initiated a Phase 1b trial with efficacy endpoints, investigating ZP9830 in people with plaque psoriasis. The trial was initiated on the back of positive topline results from the single ...